What Conditions Can Get a Cannabis Prescription in NZ?

It is the first question most people ask before booking an appointment: do I have a condition that qualifies for medical cannabis in New Zealand? The honest answer surprises people. There is no official, fixed list of qualifying conditions. Whether you can get a prescription comes down to a registered doctor's clinical judgement — and that means approval is possible for a wide range of conditions, but guaranteed for none.

This article explains how that works, which conditions prescribers most commonly consider, and what a doctor weighs up when deciding. It is general education, not medical advice — every decision is individual, and only a doctor who knows your history can make it.

Information and education, not medical or legal advice. 18+. Medical cannabis is legal in New Zealand only with a prescription from an NZ-registered doctor, dispensed through a pharmacy. Do not start, stop or change any treatment without consulting a qualified health professional.

The key fact: no list, just clinical judgement

Unlike some countries that publish a defined set of "approved conditions," New Zealand's Medicinal Cannabis Scheme does not work that way. Instead:

• Any registered doctor can prescribe most medicinal cannabis products. For the bulk of products that meet the minimum quality standard, no special licence or ministerial approval is needed.
• The decision is based on the prescriber's clinical assessment of you — your condition, your history, what you've already tried, and whether cannabis is a reasonable option.
• Because there is no statutory list, the question is less "is my condition on the list?" and more "will a doctor consider it appropriate for me?"

This is one of the most misunderstood facts about access in New Zealand. People assume the system is more closed than it is. In practice, the door is opened (or not) by an individual prescriber, not by a government checklist.

Want the full patient walkthrough? For deeper, patient-focused detail on eligibility, costs, clinics and the prescription journey, see our sister site mc.nz — built specifically for medical-cannabis patients in Aotearoa.

Conditions prescribers commonly consider

While there's no list, real-world prescribing clusters around certain conditions. New Zealand data and clinic experience point to a few dominant reasons people are prescribed cannabis-based products.

Chronic pain

Pain is one of the most common reasons for a medical cannabis prescription in New Zealand. This includes chronic non-cancer pain, neuropathic (nerve) pain, and pain that hasn't responded well to conventional treatments. An early University of Auckland study of the first 400 patients found pain among the leading reasons for use. Prescribers typically look at it where standard options have been tried and found wanting or poorly tolerated.

Sleep / insomnia

Sleep problems are another leading category. Some patients are prescribed products (including formulations featuring cannabinoids like CBN alongside THC) to help with persistent insomnia, often where it coexists with pain or anxiety. The evidence base is still developing, so prescribers weigh it carefully.

Anxiety and mental-health symptoms

New Zealand survey data points to mental health — anxiety and depression — as a major reason people seek cannabis products. This is also the most clinically nuanced area: the evidence is mixed, cannabis can help some people and worsen anxiety or paranoia in others, and responsible prescribers approach it cautiously rather than as a first-line treatment.

Multiple sclerosis (MS)

MS-related symptoms — particularly muscle spasticity and associated pain — are a well-recognised use. Notably, Sativex, a cannabis-based mouth spray, is one of the few cannabis medicines actually approved (by Medsafe) in New Zealand, with spasticity in MS among its recognised uses (though it is not Pharmac-funded).

Epilepsy

Treatment-resistant epilepsy, especially certain severe childhood seizure disorders, is one of the most evidence-backed uses of cannabinoids. Epidyolex (a purified CBD medicine) is approved in New Zealand for specific seizure conditions. These cases are typically managed by specialists.

Palliative and end-of-life care

Palliative care is an area of compassionate use, where the goal is symptom relief and quality of life — managing pain, nausea, appetite loss and distress near the end of life. The NZ Drug Foundation has championed clearer access in this setting, where the usual caution about long-term risk weighs differently.

Other conditions

Beyond these, prescribers also consider cannabis for things like nausea (including chemotherapy-related), some forms of chronic pain in older patients, and a range of individual cases. Because judgement, not a list, governs access, the field is broad — but breadth is not the same as automatic approval.

What a prescriber actually weighs up

A doctor considering medical cannabis is not just matching your condition to a category. They typically look at:

• What you've already tried. Have conventional, approved treatments been tried first, and did they fail or cause unacceptable side effects?
• Your overall health and history. Other conditions, current medications (and interactions), and family or personal history of psychosis or substance issues all matter.
• The evidence for your specific use. Stronger for epilepsy, MS spasticity and some pain; weaker and more cautious for anxiety and sleep.
• Risks vs benefits for you. Age, mental-health risk, driving and work obligations (including the 2025–26 roadside testing rules), and the cost burden, since most products are not Pharmac-funded and patients pay out of pocket.
• Practical suitability. Whether a product and dose can realistically be managed and monitored.

If those add up, a prescription is possible. If they don't — for example, if cannabis poses more risk than benefit for your situation — a responsible doctor may decline, and that is part of the system working as intended.

Why approval is never guaranteed

It bears repeating: a condition that "commonly" gets prescribed is not a guarantee for you. Two people with the same diagnosis can get different answers because their histories, medications and risk profiles differ. Some doctors are more comfortable prescribing than others; some will decline and refer you elsewhere. The absence of a fixed list cuts both ways — it opens the door wide, but it also means nobody is entitled to a prescription on diagnosis alone.

If your own GP is hesitant, that's common — many GPs decline, and a large share of patients go through telehealth clinics that focus on this area. That is a normal pathway, not a workaround.

FAQ

Is there an official list of conditions that qualify? No. New Zealand has no fixed qualifying-conditions list. Any registered doctor can prescribe most products based on their clinical judgement of your situation.

Can my regular GP prescribe it? Yes — any NZ-registered doctor can prescribe most medicinal cannabis products. In practice many patients use telehealth clinics, because not all GPs are willing to prescribe.

Does having a common condition like chronic pain guarantee a prescription? No. Common conditions are frequently prescribed for, but approval always depends on an individual clinical assessment. It is never automatic.

Is medical cannabis funded? Generally no. Pharmac funds no medicinal cannabis products; only Sativex and Epidyolex are approved medicines, and neither is subsidised. Patients typically pay out of pocket.

Where can I learn more about the patient journey? See our sister site mc.nz for patient-focused detail, and always consult a doctor about your own situation.

Sources

• Ministry of Health — about the Medicinal Cannabis Scheme: https://www.health.govt.nz/regulation-legislation/medicinal-cannabis/information-for-industry/about-the-medicinal-cannabis-scheme
• Ministry of Health — medicinal cannabis information for consumers: https://www.health.govt.nz/regulation-legislation/medicinal-cannabis/information-for-consumers
• Ministry of Health — products meeting the minimum quality standard: https://www.health.govt.nz/regulation-legislation/medicinal-cannabis/information-for-health-professionals/minimum-quality-standard-medicinal-cannabis-products
• Medsafe — approved medicines (Sativex, Epidyolex): https://www.medsafe.govt.nz/
• bpacnz — medicinal cannabis: overview for health practitioners: https://bpac.org.nz/2022/medicinal-cannabis.aspx
• Healthify — cannabis-based products: https://healthify.nz/medicines-a-z/c/cannabis-based-products/
• University of Auckland — first 400 patients study (anxiety, chronic pain, sleep): https://www.auckland.ac.nz/en/news/2020/02/05/medical-cannabis-may-ease-anxiety-chronic-pain.html
• Massey University — one-third of medical cannabis users now have a prescription: https://www.massey.ac.nz/about/news/survey-shows-one-third-of-medical-cannabis-users-now-have-a-prescription-for-legal-prescribed-cannabis-products/
• Pharmac — funding for medicinal cannabis products: https://www.pharmac.govt.nz/medicine-funding-and-supply/the-funding-process/from-application-to-funded-medicine-how-we-fund-a-medicine/funding-for-medicinal-cannabis-products

Last reviewed 15 June 2026. weed.nz publishes information and education, not medical advice. Always consult a registered doctor about your own health.